CAS: 2390-54-7; 2-(4-(Dimethylamino)Phenyl)-3,6-Dimethylbenzo[d]Thiazol-3-Ium Chloride

该化合物是Thioflavin T, 是一种合成有机化合物,通常用作生物化学和分子生物学中的荧光染色剂,其特点是它能够与氨基纤维素结合,使其成为研究蛋白集合和误叠,特别是诸如阿尔茨海默症等...

结构式图片

相似化合物

92-36-4 10205-62-6 10205-71-7

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

methanol 2-(4-aminophenyl)-6-methyl-1,3-benzothiazole N,N-dimethyl-4-(6-methylbenzo[d]thiazole-2-yl)aniline methyl iodideN,N-dimethyl-4-(6-methylbenzo[d]thiazole-2-yl)aniline [2-(4-(dimethylamino)phenyl)-3,6-dimethylbenzo[d]thiazol-3-ium] iodide

合成工艺路线路线简述

    N,N,N-Trimethyl-4-(6-Methyl-Benzothiazol-2-yl)-Anilinium; Chloride 反应生成硫黄素 T
    参考文献:驱虫性季盐.3.苯并噻唑盐.
    标题:驱虫性季盐.3.苯并噻唑盐.
    摘要:
    Doi:10.1021/jm00301A008

    海关参考信息

    专利信息


    专利号:US-9868783-B2
    优先权日:2013-07-04
    标 题:Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus
    发明人:DI NARDO ARIEL; MOYA KENNETH LEE; ARNAUD KAREN; PROCHIANTZ ALAIN
    权利人:CENTRE NAT RECH SCIENT; COLLEGE FRANCE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE (INSERM); INST NAT SANTE RECH MED
    摘要:The invention relates to the treatment of neurodegenerative diseases, in particular Alzheimer's disease, by inhibition of the synthesis of βAPP or of the activity of the Aβ peptide in the choroid plexus.

    专利号:US-9662347-B2
    优先权日:2010-05-11
    标题 :Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system
    发明人:LEE BONG HEE; BYUN KYUNG HEE
    权利人:LEE BONG HEE; BYUN KYUNG HEE; GACHON UNIV OF INDUSTRY-ACADEMIC COOP FOUND
    摘要:The present invention relates to a method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of AGE-albumin in cells of the mononuclear phagocyte system, to an AGE-albumin synthesis inhibitor, and to a pharmaceutical composition comprising the AGE-albumin synthesis inhibitor for preventing or treating degenerative disease and autoimmune disease. The AGE-albumin of the present invention is synthesized and secreted in human microglia or human macrophages in an Alzheimer's model, stroke model, Parkinson's disease model and rheumatoid arthritis model. The AGE-albumin synthesis and secretion are caused by oxidative stress. The expression of RAGE increases in first-order human neurons or cartilage cells to which AGE-albumin is administered, whereupon a MAPK signaling pathway is activated and the expression of Bax increases to induce an increase in calcium in mitochondria, thus finally inducing cell death. Therefore, the AGE-albumin synthesis inhibitor of the present invention can be valuably used in the diagnosis or treatment of degenerative diseases or autoimmune diseases such as Alzheimer's disease, strokes, Parkinson's disease, amyotrophic lateral sclerosis, rheumatoid arthritis, diabetic retinopathy, AIDS, aging, pulmonary fibrosis, spinal cord injuries, etc.

    专利号:WO-2024199465-A1
    优先权日:2023-03-30
    标 题:Unnatural amino acid in cellulo synthesis for site-specific protein modification
    发明人:CHAN MICHAEL KENNETH; LEE MARIANNE; CHENG JIAHUI
    权利人:UNIV HONG KONG CHINESE
    摘要:Provided are genetically modified host cells containing engineered enzymes that support the synthesis of unnatural amino acids, such as D-Cys-ε-Lys, and the incorporation of such unnatural amino acids into a newly synthesized protein. These cells are therefore capable of in vivo or in cellulo synthesis of a protein containing one or more unnatural amino acids strategically placed at pre-determined locations for site-specific modification of the protein. Also provided are the corresponding methods for in vivo synthesis of modified proteins as well as the modified proteins produced by the method.

    专利号:US-9133176-B2
    优先权日:2002-02-15
    标题:Isolation, purification and synthesis of procyanidin B2 and uses thereof
    发明人:CASTILLO GERARDO; NGUYEN BETH; CHOI PAULA; LARSEN LESLEY; LORIMER STEPHEN; SNOW ALAN
    权利人:CASTILLO GERARDO; NGUYEN BETH; CHOI PAULA; LARSEN LESLEY; LORIMER STEPHEN; SNOW ALAN; PROTEOTECH INC
    摘要:Methods for the synthesis, isolation, and purification of procyanidin B2 are disclosed. The synthetic methods utilize epicatechin as a starting material and produce procyanidin B2 in high yields. The isolation methods extract procyanidin B2 from a sample of bark powder from plant matter of the genus Uncaria . The isolated and/or synthesized procyanidin B2 is used to treat amyloid disease, such as Alzheimer's disease and Parkinson's disease as well as improve cognitive performance and increase learning and memory in Alzheimer's patients. Pharmaceutical compositions containing the synthesized and/or isolated procyanidin B2 are also disclosed.

    专利号:US-2013243770-A1
    优先权日:2005-10-14
    标 题:Treating diabetes using inhibitors of il-1
    发明人:LAU JESPER
    权利人:NOVO NORDISK AS
    摘要:The present invention describes a method of treating diabetes or metabolic syndrome with a compound that inhibits (a) IL-1, (b) the synthesis of IL-1, or (c) the release of IL-1.

    专利号:US-9580480-B2
    优先权日:2011-05-31
    标题:Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
    发明人:LU TIMOTHY KUAN-TA; CHEN ALLEN YUYIN
    权利人:LU TIMOTHY KUAN-TA; CHEN ALLEN YUYIN; MASSACHUSETTS INST TECHNOLOGY
    摘要:Aspects of the invention relate to the engineering of biological nanostructures and materials.
    武汉市罗氏科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.luoshikg.com
    企业联系电话:18986168071;19307247857👤
    📞武汉市罗氏科技发展有限公司 ⚠️参考联系方式
    联系人:罗经理;祝经理
    电话:18986168071;19307247857
    手机:18986168071;19307247857
    传真:027-88121016;QQ1712680783
    邮箱:18986168071@163.com
    通信地址: 湖北省武汉市洪山区洪山工业园
    邮编: 430064
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市洪山区洪山工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海东满进出口有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.domen.com.cn
    企业联系电话:021-61066956/57/58,61043548👤
    📞上海东满进出口有限公司 ⚠️参考联系方式
    联系人:董连锁
    电话:021-61066956/57/58,61043548

    传真:021-61043546
    邮箱:sales@domen.com.cn
    通信地址: 上海市浦东新区新金桥路1088号中惠广场A座1907室
    邮编: 201206
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区新金桥路1088号中惠广场A座1907室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北亚隆新材料有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.whylxcl.cn
    企业联系电话:027-86643577;李15377505605;陶15527268657👤
    📞湖北亚隆新材料有限公司 ⚠️参考联系方式
    联系人:李总
    电话:027-86643577;李15377505605;陶15527268657
    手机:15377507605
    传真:027-86643577
    邮箱:1057540201@qq.com
    通信地址: 湖北武汉东湖新技术开发区国际企业中心
    邮编: 430000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北武汉东湖新技术开发区国际企业中心
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Schlein M. Insulin Formulation Characterization-the Thioflavin T Assays. AAPS J. 2017 Mar;19(2):397-408. doi: 10.1208/s12248-016-0028-6. Epub 2016 Dec 20. Review. doi: 10.1016/j.ijbiomac.2016.05.014. Epub 2016 May 6. Review. doi: 10.3389/fneur.2016.00053. eCollection 2016. Review.
    4: Xu MM, Ren WM, Tang XC, Hu YH, Zhang HY. Advances in development of fluorescent probes for detecting amyloid-β aggregates. Acta Pharmacol Sin. 2016 Jun;37(6):719-30. doi: 10.1038/aps.2015.155. Epub 2016 Mar 21. Review.
    5: Naiki H, Okoshi T, Ozawa D, Yamaguchi I, Hasegawa K. Molecular pathogenesis of human amyloidosis: Lessons from β2 -microglobulin-related amyloidosis. Pathol Int. 2016 Apr;66(4):193-201. doi: 10.1111/pin.12394. Epub 2016 Mar 11. Review. doi: 10.18097/PBMC20156102203. Review. Russian. doi: 10.2147/DDDT.S72165. eCollection 2015. Review.

    合成参考文献


    参考文献:10.1371/journal.pone.0021880
    摘要:Katsouri L, Georgopoulos S. Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model. PLoS ONE. 2011 Jul 06;6(7):e21880. doi: 10.1371/journal.pone.0021880.
    参考文献:10.1097/nen.0b013e318225038c
    摘要:Poduslo JF, Hultman KL, Curran GL, Preboske GM, Chamberlain R, Marjańska M, Garwood M, Jack CR, Wengenack TM. Targeting Vascular Amyloid in Arterioles of Alzheimer Disease Transgenic Mice With Amyloid β Protein Antibody-Coated Nanoparticles. J Neuropathol Exp Neurol. 2011 Aug;70(8):653–61. doi: 10.1097/nen.0b013e318225038c.
    参考文献:10.1021/cn300030a
    摘要:Planchard MS, Samel MA, Kumar A, Rangachari V. The natural product betulinic acid rapidly promotes amyloid-β fibril formation at the expense of soluble oligomers. ACS Chem Neurosci. 2012 Nov 21;3(11):900–8.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知